Cmed nabs £5m growth cap investment
By Real Deals & Real Business, published 1 year ago in Business Technology.
Scottish Equity Partners has made a £5m growth capital investment in Cmed Group, a Horsham-based provider of clinical research data services to the pharmaceutical and biotech industries.
Comments
Add a commentRelated Content
- Terry List – List Group
- Nicole Farhi sold to US private equity group
- Tips to secure investment for business growth
More from this section
The company, which was founded in 1999, will use funds for the global expansion of its Timaeus product, a single, purpose-designed intelligent data acquisition and management service.
Timaeus’s advantages over rival systems include rapid set-up and the ability to deal with complex clinical studies, according to the company.
In addition, the offering also operates over low bandwidth, enabling GSM and GPRS wireless connection with remote clinical trial sites, as well as web use.
Timaeus has already been implemented by a number of pharma and biotech companies.
Headquartered in the UK, Cmed also has bases in the US and Romania.
Picture source
0 comments.
There are currently no comments. Be the first...